Ralvenius, William T.
Neumann, Elena
Pagani, Martina
Acuña, Mario A.
Wildner, Hendrik
Benke, Dietmar http://orcid.org/0000-0003-1846-4711
Fischer, Nina
Rostaher, Ana
Schwager, Simon
Detmar, Michael http://orcid.org/0000-0002-5351-5054
Frauenknecht, Katrin
Aguzzi, Adriano http://orcid.org/0000-0002-0344-6708
Hubbs, Jed Lee
Rudolph, Uwe
Favrot, Claude
Zeilhofer, Hanns Ulrich http://orcid.org/0000-0001-6954-4629
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (156393)
EC | European Research Council (DHISP 250128)
Deutsche Forschungsgemeinschaft (NE 2126/1-1)
Hartmann Müller Stiftung Stavros Niarchos Foundation
Article History
Received: 18 May 2018
Accepted: 20 July 2018
First Online: 13 August 2018
Competing interests
: W.T.R. and H.U.Z. have submitted a patent application on the use of TPA023B or related compounds against itch. Neurocycle Therapeutics has licensed this patent. J.L.H. is a founder of this company. The remaining authors declare no competing interests.